Paris, France

Camille Legros

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Tissium Sa. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Camille Legros. Retrieved from https://idiyas.com/inventor/camille-legros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Camille Legros - Innovator in Medical Adhesives

Introduction

Camille Legros is a talented inventor based in Paris, France. She is currently associated with Tissium SA, a company focused on developing innovative medical solutions. Despite having no granted patents to her name, her contributions to the field of medical adhesives are noteworthy.

Latest Patent Applications

Camille Legros has filed several patent applications that showcase her innovative ideas. One of her latest applications is titled "COMPOSITION COMPRISING ACTIVATED AND FUNCTIONALIZED PRE-POLYMER." This application relates to a composition that includes a pre-polymer with activated groups and negatively charged functional groups on a polymeric backbone. Another application, "COMPOSITION COMPRISING ACTIVATED AND FUNCTIONALIZED PREPOLYMER," describes a composition that may be used for adhering or sealing tissue, or for attaching a medical device to the surface of tissue.

Conclusion

Camille Legros is an emerging inventor whose work in medical adhesives holds promise for future advancements in the field. Her innovative patent applications reflect her commitment to improving medical technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…